Countries Japan

GHIT Fund Allocates JPY 1.64 Billion to Combat Malaria and Neglected Tropical Diseases Through Innovative Partnerships

The Global Health Innovative Technology (GHIT) Fund  announced a substantial investment of approximately JPY 1.64 billion (USD 10.8 million) dedicated...

 May 09, 2024 | News

C₂N Diagnostics Partners with Mediford Corporation to Expand Alzheimer's Research Services in Japan

-C₂N Diagnostics, LLC (“C2N”), a specialty diagnostics company with a vision to bring Clarity Through Innovation®, today announced a part...

 April 29, 2024 | News

PRISM BioLab and ONO Pharmaceutical Forge Strategic Collaboration to Advance Oncology Drug Development

PRISM BioLab, Co. Ltd. ("PRISM"), a leading discovery and development biotechnology company designing small molecule inhibitors of protein-protein int...

 April 26, 2024 | News

AGC Biologics Completes Production of VAR2 Pharmaceuticals' Cancer-Targeting Antibodies

AGC Biologics announced the completion of work with VAR2 Pharmaceuticals on the production of the company’s two antibody candidates targeti...

 April 25, 2024 | News

AGC Biologics Expands in Yokohama with Advanced Biomanufacturing Hub Featuring Cytiva Technology

  New AGC Biologics facility in Yokohama strengthens access to world-class biomanufacturing in Japan, offering mammalian, mRNA and cell therapy ser...

 April 23, 2024 | News

WuXi AppTec's Changzhou Facility Gains PMDA Approval, Bolstering Global Expansion Plans

Latest regulatory approval follows on the back of expansion plans announced during DCAT 2024   With peptides, oligos and peptide conjugates continui...

 April 22, 2024 | News

Eisai Launches Injectable Fycompa in Japan for Epilepsy Treatment

Eisai Co., Ltd. announcedthat the injection formulation of its in-house discovered antiepileptic drug (AED) Fycompa (perampanel hydrate) for intravenous (I...

 April 19, 2024 | News

Bloomage Secures Global Trust with Comprehensive Compliance, Passing Japan's PMDA Audit and Other International Inspections

Bloomage recently successfully completed the on-site Good Manufacturing Practice (GMP) audit conducted by Japan's Pharmaceuticals and M...

 April 16, 2024 | Regulatory

Asahi Kasei Bioprocess and Axolabs Partner to Boost Oligonucleotide Therapy Development

Asahi Kasei Bioprocess (AKB), part of the Asahi Kasei Group, and Axolabs have announced a strategic partnership in the burgeoning field of oligonucleotide ...

 April 12, 2024 | News

Nanoform Finland Plc Partners with CBC Co., Ltd. to Transform Japanese Pharmaceutical Industry with Nanotechnology

Nanoform Finland Plc ("Nanoform")  announced a strategic partnership whereby CBC Co., Ltd. ("CBC"), will utilize its extensive experience in the Japan...

 April 12, 2024 | News

ACROBiosystems Debuts 3D Organoid Solutions for Biotherapeutic Research

ACROBiosystems has been continuously rolling out a series of innovative organoid-related products. At a range of significant international events, includin...

 April 11, 2024 | News

Eisai and Biogen Seek FDA Approval for Monthly Alzheimer's Treatment Dosing

Eisai Co., Ltd. and Biogen Inc. have taken a significant step forward in the fight against Alzheimer’s disease by submitting a Supplemental Biologics...

 April 01, 2024 | News

Resonance Health Joins Forces with Micron, Inc. for Strategic Entry into Japan's Healthcare Sector

Resonance Health Ltd, listed on the Australian Securities Exchange (ASX) under the ticker RHT, has officially announced its strategic move into the Japanes...

 March 28, 2024 | News

Takeda Receives FDA Approval for ICLUSIG as a First-Line Treatment in Ph+ ALL

Takeda Receives FDA Approval for ICLUSIG as a First-Line Treatment in Ph+ ALL   Takeda Pharmaceutical Company Limited (TSE: 4502; NYSE: TAK) is plea...

 March 25, 2024 | News


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close